Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Opatrný

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Vnitrni Lekarstvi|September 1, 1988
[Hemostasis in patients with chronic kidney failure treated with long-term hemodialysis]K Opatrný, V Cepelák, K Opatrný
Vnitrni Lekarstvi|June 25, 2004
[The first conferences of dialysis nurses and staff in Czechoslovakia]K Opatrný
Vnitrni Lekarstvi|August 25, 2004
[Results of proteomic-based study of the kidney, urine, plasma, and uremic ultrafiltrate. Potential applications of the results in nephrology]K Opatrný
Casopis Lekaru Ceskych|October 17, 1986
[Resonance thrombography, a new method for studying hemostasis]K Opatrný, V Cepelák, K Opatrný, et al.
Casopis Lekaru Ceskych|January 30, 2004
[Pure red cell aplasia in erythropoietin therapy in patients with kidney failure]K Opatrný
Vnitrni Lekarstvi|December 1, 1996
[Methods of continuous extracorporeal replacement of renal function]K Opatrný
American Journal of Nephrology|June 17, 1998
Tissue-type plasminogen activator (tPA) and its inhibitor (PAI-1) in patients treated with continuous ambulatory peritoneal dialysisK Opatrný, S Opatrná, L Vít, et al.
Kidney International. Supplement|November 14, 1997
Hemostasis disorders in chronic renal failureK Opatrný
Vnitrni Lekarstvi|May 8, 2003
[Acute adverse effects of dialysis]K Opatrný
Vnitrni Lekarstvi|July 1, 1986
[The effect of long-term hemodialysis treatment on hemostasis indicators]K Opatrný, V Cepelák, K Opatrný, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Vnitrni Lekarstvi|September 1, 1988
[Hemostasis in patients with chronic kidney failure treated with long-term hemodialysis]K Opatrný, V Cepelák, K Opatrný
Vnitrni Lekarstvi|June 25, 2004
[The first conferences of dialysis nurses and staff in Czechoslovakia]K Opatrný
Vnitrni Lekarstvi|August 25, 2004
[Results of proteomic-based study of the kidney, urine, plasma, and uremic ultrafiltrate. Potential applications of the results in nephrology]K Opatrný
Casopis Lekaru Ceskych|October 17, 1986
[Resonance thrombography, a new method for studying hemostasis]K Opatrný, V Cepelák, K Opatrný, et al.
Casopis Lekaru Ceskych|January 30, 2004
[Pure red cell aplasia in erythropoietin therapy in patients with kidney failure]K Opatrný
Vnitrni Lekarstvi|December 1, 1996
[Methods of continuous extracorporeal replacement of renal function]K Opatrný
American Journal of Nephrology|June 17, 1998
Tissue-type plasminogen activator (tPA) and its inhibitor (PAI-1) in patients treated with continuous ambulatory peritoneal dialysisK Opatrný, S Opatrná, L Vít, et al.
Kidney International. Supplement|November 14, 1997
Hemostasis disorders in chronic renal failureK Opatrný
Vnitrni Lekarstvi|May 8, 2003
[Acute adverse effects of dialysis]K Opatrný
Vnitrni Lekarstvi|July 1, 1986
[The effect of long-term hemodialysis treatment on hemostasis indicators]K Opatrný, V Cepelák, K Opatrný, et al.
Pageof 10